Your browser doesn't support javascript.
loading
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?
Tamari, R; Mughal, T I; Rondelli, D; Hasserjian, R; Gupta, V; Odenike, O; Fauble, V; Finazzi, G; Pane, F; Mascarenhas, J; Prchal, J; Giralt, S; Hoffman, R.
Afiliação
  • Tamari R; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mughal TI; Division of Hematology and Oncology, Tufts Medical Center, Boston, MA, USA.
  • Rondelli D; University of Illinois, Chicago, IL, USA.
  • Hasserjian R; Dana Farber Cancer Institute, Boston, MA, USA.
  • Gupta V; Princess Margaret Cancer Center, Toronto, Canada.
  • Odenike O; University of Chicago, Chicago, IL, USA.
  • Fauble V; Mayo Clinic Cancer Center, Scottsdale, AZ, USA.
  • Finazzi G; Papa Giovani XXIII Hospital and Research Center, Bergamo, Italy.
  • Pane F; Federico II University, Naples, Italy.
  • Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Prchal J; Huntsman Cancer Center, Salt Lake City, UT, USA.
  • Giralt S; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Bone Marrow Transplant ; 50(5): 628-36, 2015 May.
Article em En | MEDLINE | ID: mdl-25665047

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Transplante de Células-Tronco / Janus Quinases / Mielofibrose Primária Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Transplante de Células-Tronco / Janus Quinases / Mielofibrose Primária Idioma: En Ano de publicação: 2015 Tipo de documento: Article